https://www.taxtmi.com/news?id=35028 The strategic alliance combines AGENOME's Biobank and sequence data with TIGS functional genomics expertise to discover actionable genetic markers, develop population-scale diagnostics and screening assays (including CRISPR approaches), evaluate mRNA therapeutics and in vivo gene therapy potential, and profile pharmacogenomic markers for precision medicine. Governance is vested in a co-chaired Joint Steering Committee to oversee research priorities, data use, ethical safeguards and commercialization strategies, with a stated commitment to accessibility of resulting knowledge and interventions for affected communities and broader populations. en-us Mon, 24 Feb 2025 13:01:03 +0530 Mon, 24 Feb 2025 13:01:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=35028 The strategic alliance combines AGENOME's Biobank and sequence data with TIGS functional genomics expertise to discover actionable genetic markers, develop population-scale diagnostics and screening assays (including CRISPR approaches), evaluate mRNA therapeutics and in vivo gene therapy potential, and profile pharmacogenomic markers for precision medicine. Governance is vested in a co-chaired Joint Steering Committee to oversee research priorities, data use, ethical safeguards and commercialization strategies, with a stated commitment to accessibility of resulting knowledge and interventions for affected communities and broader populations. News - Mon, 24 Feb 2025 13:01:03 +0530 https://www.taxtmi.com/news?id=35028